Coloplast 9M report: Continued EBIT margin improvements

During the first 9 months of 2009/10 Coloplast shows organic growth of 7% and
an EBIT margin of 20% against 15% last year. 

”I am very satisfied. We continue to improve our margins faster than expected
even though we have had high costs this year due to the transfer of production.
Furthermore, I am particularly pleased with the fact that we have increased
growth in our Ostomy business from 3% to 7% in just one year”, says CEO Lars
Rasmussen. 

Based on the results Coloplast now expects an EBIT margin for the year of 20%
against the previous forecast of 19-20%. Consequently, Coloplast fulfills the
long-term target of a profit margin of 20% this year. 

”The results show that our long-term expectations have been ambitious, but
realistic. For quite a long period now we have shown improvement in performance
and cost discipline - a development which underlines the potential of
Coloplast”, says Lars Rasmussen. 

Coloplast expects an organic growth rate for the year of 6-7% and 7-8% in DKK.

PRESS CONTACT
Morten Sørensen
Media Relations Manager 
+45 4911 2632
dkmoso@coloplast.com
	
INVESTOR RELATIONS
Ian S. E. Christensen
Director of Investor Relations 
+45 4911 1301
dkisec@coloplast.com